Luciano Adorini
PHD
- Luciano has served as Intercept’s Chief Scientific Officer from 2008 until recently when he has named Head of External Scientific Research. He has over 30 years of pharmaceutical industry experience.
- He was a co-founder and Chief Scientific Officer at BioXell S.p.A., where he was responsible for advancing a pipeline of products based on vitamin D receptor agonists in multiple disease indications. During his tenure, BioXell raised significant capital from international venture capital firms, and was listed at the Swiss stock exchange.
- Earlier in his career, he served as associate director of Roche Milano Ricerche, and was research director of a unit at the Preclinical Research Center, Sandoz Pharma, Ltd., in Basel, Switzerland.
- He has authored over 300 journal articles and other scientific publications, becoming a highly cited researcher in immunology, with a focus on immune suppressive and immunoregulatory mechanisms in the treatment of inflammatory and autoimmune diseases. He is a board member of a number of peer-reviewed publications and has served as president of the Italian Society of Immunology, Clinical Immunology and Allergology.